MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 229 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $170 | +25.9% | 607 | +20.2% | 0.00% | 0.0% |
| Q1 2024 | $135 | -72.4% | 505 | -76.2% | 0.00% | -75.0% |
| Q4 2023 | $490 | +62.8% | 2,119 | +2.8% | 0.00% | +33.3% |
| Q3 2023 | $301 | -36.0% | 2,062 | +1.4% | 0.00% | -25.0% |
| Q2 2023 | $470 | +7.6% | 2,033 | +12.7% | 0.00% | 0.0% |
| Q1 2023 | $437 | -28.1% | 1,804 | -13.9% | 0.00% | -20.0% |
| Q4 2022 | $608 | -99.5% | 2,096 | +2.3% | 0.01% | +400.0% |
| Q3 2022 | $133,000 | -8.3% | 2,049 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $145,000 | -22.9% | 2,019 | +5.2% | 0.00% | 0.0% |
| Q1 2022 | $188,000 | -10.0% | 1,919 | -10.5% | 0.00% | -50.0% |
| Q2 2021 | $209,000 | -15.7% | 2,145 | +141.6% | 0.00% | -66.7% |
| Q2 2018 | $248,000 | – | 888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |